ESCALATing care? Eltrombopag in pediatric aplastic anemia
Saved in:
| Main Authors: | Joshua Glass, Emma M. Groarke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952925003088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of eltrombopag in severe aplastic anemia treatment in children
by: Min-Yu Su, et al.
Published: (2021-11-01) -
Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials
by: Huaipeng Guo, et al.
Published: (2024-12-01) -
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
by: Monica Carpenedo, et al.
Published: (2024-12-01) -
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy
by: Jibran Durrani, et al.
Published: (2025-06-01) -
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy
by: Zhijie Wu, et al.
Published: (2025-05-01)